Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome. Alternative splicing results in multiple transcript variants.
Human Integral membrane protein DGCR2/IDD (DGCR2) ELISA Kit employs a two-site sandwich ELISA to quantitate DGCR2 in samples. An antibody specific for DGCR2 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyDGCR2 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for DGCR2 is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of DGCR2 bound in the initial step. The color development is stopped and the intensity of the color is measured.
Human Integral membrane protein DGCR2/IDD (DGCR2) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Find more details at http://www.abbkine.com/product/human-integral-membrane-protein-dgcr2-idd-dgcr2-elisa-kit-kte62086/
bio-equip.cn
Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.